Regorafenib induced severe toxic hepatitis: characterization and discussion.
about
Fatal Acute Liver Failure as a Consequence of Regorafenib Treatment in a Metastatic Colon Cancer.Regorafenib-induced retinal and gastrointestinal hemorrhage in a metastatic colorectal cancer patient with liver dysfunction: A case report.Mechanisms of toxicity associated with six tyrosine kinase inhibitors in human hepatocyte cell lines.Evolution of regorafenib from bench to bedside in colorectal cancer: Is it an attractive option or merely a "me too" drug?Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
P2860
Regorafenib induced severe toxic hepatitis: characterization and discussion.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Regorafenib induced severe toxic hepatitis: characterization and discussion.
@en
Regorafenib induced severe toxic hepatitis: characterization and discussion.
@nl
type
label
Regorafenib induced severe toxic hepatitis: characterization and discussion.
@en
Regorafenib induced severe toxic hepatitis: characterization and discussion.
@nl
prefLabel
Regorafenib induced severe toxic hepatitis: characterization and discussion.
@en
Regorafenib induced severe toxic hepatitis: characterization and discussion.
@nl
P2093
P2860
P356
P1433
P1476
Regorafenib induced severe toxic hepatitis: characterization and discussion
@en
P2093
Achim Weber
Anne Sacré
Anne-France Dekairelle
Astrid De Cuyper
Daniela Leggenhager
Hélène Dano
Jean-Luc Gala
Marc Van den Eynde
Selda Aydin
Yves Humblet
P2860
P304
P356
10.1111/LIV.13217
P577
2016-09-06T00:00:00Z